[Fatty pancreas disease: clinical impact]
- PMID: 30590942
[Fatty pancreas disease: clinical impact]
Abstract
Pancreatic steatosis is the name for a state characterized by an increased accumulation of fat in the pancreas. It is most frequently due to obesity and the metabolic syndrome, other etiological factors may include some congenital syndromes, toxic substances or viral diseases. Diagnostics is based on non-invasive imaging methods. The most accessible is abdominal ultrasound, also endoscopic ultrasound, computed tomography or magnetic resonance imaging can be used. In clinical practice, pancreatic steatosis is in particular significant because of its close association with type 2 diabetes mellitus, non-alcoholic fatty liver disease and cardiovascular diseases. The disorder may aggravate the burden of acute pancreatitis, examined is its relationship to pancreatic cancer. Significant are also surgical reports on complications after pancreatic surgeries on individuals with pancreatic steatosis. Key words: acute pancreatitis - dyslipidemia - fatty pancreas - non-alcoholic fatty pancreas disease - non-alcoholic steatopancreatitis - obesity - pancreatic carcinoma.
Keywords: acute pancreatitis - dyslipidemia - fatty pancreas - non-alcoholic fatty pancreas disease - non-alcoholic steatopancreatitis - obesity - pancreatic carcinoma.
Similar articles
-
Non-alcoholic fatty pancreas disease.Postgrad Med J. 2017 Apr;93(1098):226-230. doi: 10.1136/postgradmedj-2016-134546. Epub 2017 Jan 9. Postgrad Med J. 2017. PMID: 28069746 Review.
-
Nonalcoholic Fatty Pancreas Disease: Clinical Consequences.Dig Dis. 2020;38(2):143-149. doi: 10.1159/000505366. Epub 2019 Dec 19. Dig Dis. 2020. PMID: 31865317 Review.
-
Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review.Endocr Metab Immune Disord Drug Targets. 2018;18(6):547-554. doi: 10.2174/1871530318666180328111302. Endocr Metab Immune Disord Drug Targets. 2018. PMID: 29595117 Review.
-
PANCREATIC STEATOSIS: A NEW DIAGNOSIS AND THERAPEUTIC CHALLENGE IN GASTROENTEROLOGY.Arq Gastroenterol. 2020 Apr-Jun;57(2):216-220. doi: 10.1590/s0004-2803.202000000-27. Arq Gastroenterol. 2020. PMID: 32490903
-
The association between pancreas steatosis and metabolic syndrome: A systematic review and meta-analysis.Diabetes Metab Res Rev. 2019 Jul;35(5):e3142. doi: 10.1002/dmrr.3142. Epub 2019 Mar 4. Diabetes Metab Res Rev. 2019. PMID: 30767421
Cited by
-
Causes of Exocrine Pancreatic Insufficiency Other Than Chronic Pancreatitis.J Clin Med. 2021 Dec 10;10(24):5779. doi: 10.3390/jcm10245779. J Clin Med. 2021. PMID: 34945075 Free PMC article. Review.
-
Metabolic Syndrome and Abnormal Peri-Organ or Intra-Organ Fat (APIFat) Deposition in Chronic Obstructive Pulmonary Disease: An Overview.Metabolites. 2020 Nov 15;10(11):465. doi: 10.3390/metabo10110465. Metabolites. 2020. PMID: 33203192 Free PMC article. Review.
-
The Role of Endoscopic Ultrasound-Guided Shear Wave Elastography in Pancreatic Diseases.Diagnostics (Basel). 2024 Oct 19;14(20):2329. doi: 10.3390/diagnostics14202329. Diagnostics (Basel). 2024. PMID: 39451652 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical